Insider · CIK 0001567160

Gano Kyle

CIK 0001567160 Name as filed on the most recent filing

Filed as Gano Kyle (49)

75 transaction lines · from 49 filings · filed 2013-09-05 to 2026-01-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

75 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-01-16 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 4,830,458, disposed Open Form 4 filing 0001567160-26-000002
2025-11-04 S, Open-market sale Neurocrine Biosciences IncNBIX 42,591, disposed Open Form 4 filing 0001567160-25-000008
2025-02-13 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 298,908, disposed Open Form 4 filing 0000914475-25-000063
2025-02-10 S, Open-market sale Neurocrine Biosciences IncNBIX 116,020, disposed Open Form 4 filing 0000914475-25-000049
2025-01-31 S, Open-market sale Neurocrine Biosciences IncNBIX 235,577, disposed Open Form 4 filing 0000914475-25-000025
2025-01-15 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 9,197,550, disposed Open Form 4 filing 0000914475-25-000004
2024-02-13 S, Open-market sale Neurocrine Biosciences IncNBIX 179,674, disposed Open Form 4 filing 0000914475-24-000072
2024-02-08 S, Open-market sale Neurocrine Biosciences IncNBIX 131,519, disposed Open Form 4 filing 0000914475-24-000045
2024-02-06 S, Open-market sale Neurocrine Biosciences IncNBIX 227,522, disposed Open Form 4 filing 0000914475-24-000045
2024-01-31 S, Open-market sale Neurocrine Biosciences IncNBIX 216,813, disposed Open Form 4 filing 0000914475-24-000027
2024-01-02 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 9,860,194, disposed Open Form 4 filing 0000914475-24-000007
2023-08-21 S, Open-market sale Neurocrine Biosciences IncNBIX 228,993, disposed Open Form 4 filing 0001209191-23-047135
2023-02-08 S, Open-market sale Neurocrine Biosciences IncNBIX 101,910, disposed Open Form 4 filing 0001209191-23-007910
2023-02-07 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 1,476,982, disposed Open Form 4 filing 0001209191-23-007910
2023-02-06 S, Open-market sale Neurocrine Biosciences IncNBIX 169,028, disposed Open Form 4 filing 0001209191-23-007910
2023-01-31 S, Open-market sale Neurocrine Biosciences IncNBIX 169,486, disposed Open Form 4 filing 0001209191-23-006275
2022-02-08 S, Open-market sale Neurocrine Biosciences IncNBIX 78,079, disposed Open Form 4 filing 0001209191-22-008207
2022-02-07 S, Open-market sale Neurocrine Biosciences IncNBIX 4 lines 476,549, disposed Open Form 4 filing 0001209191-22-008207
2022-01-05 S, Open-market sale Neurocrine Biosciences IncNBIX 2,416,751, disposed Open Form 4 filing 0001209191-22-002529
2021-02-08 S, Open-market sale Neurocrine Biosciences IncNBIX 3 lines 431,518, disposed Open Form 4 filing 0001209191-21-009134
2021-02-05 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 305,184, disposed Open Form 4 filing 0001209191-21-009134
2020-11-12 S, Open-market sale Neurocrine Biosciences IncNBIX 204,770, disposed Open Form 4 filing 0001209191-20-058543
2020-08-05 S, Open-market sale Neurocrine Biosciences IncNBIX 268,286, disposed Open Form 4 filing 0001209191-20-045749
2020-04-24 S, Open-market sale Neurocrine Biosciences IncNBIX 192,377, disposed Open Form 4 filing 0001209191-20-026066
2020-02-07 S, Open-market sale Neurocrine Biosciences IncNBIX 167,710, disposed Open Form 4 filing 0001209191-20-008491
2020-02-06 S, Open-market sale Neurocrine Biosciences IncNBIX 101,413, disposed Open Form 4 filing 0001209191-20-007695
2020-02-05 S, Open-market sale Neurocrine Biosciences IncNBIX 3 lines 380,262, disposed Open Form 4 filing 0001209191-20-007695
2019-02-06 S, Open-market sale Neurocrine Biosciences IncNBIX 63,673, disposed Open Form 4 filing 0001209191-19-008630
2019-02-05 S, Open-market sale Neurocrine Biosciences IncNBIX 3 lines 214,482, disposed Open Form 4 filing 0001209191-19-007849
2019-02-04 S, Open-market sale Neurocrine Biosciences IncNBIX 121,186, disposed Open Form 4 filing 0001209191-19-007849
2018-08-01 S, Open-market sale Neurocrine Biosciences IncNBIX 3,250,590, disposed Open Form 4 filing 0001209191-18-045265
2018-03-05 S, Open-market sale Neurocrine Biosciences IncNBIX 2,128,500, disposed Open Form 4 filing 0001209191-18-017709
2018-02-05 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 169,914, disposed Open Form 4 filing 0001209191-18-008204
2018-01-16 S, Open-market sale Neurocrine Biosciences IncNBIX 128,460, disposed Open Form 4 filing 0001209191-18-004237

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 75
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Gano Kyle, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001567160

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.